Taylor Ian

President, R&D at ARVN

Sold, on record
$7.7M
Dollars the filings state
Form 4 sales
13
Latest Feb 24, 2025
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • ARVNARVINAS, INC.President, R&D

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale ARVNPlan not stated
    Apr 5, 2021 2021

    Sold 25,000 shares at $66.81 ($1.7M)

    Taylor Ian, Chief Scientific Officer

    Sold 24.1% of holdings ($6.9M position)78,645 shares left2.5x usual sizeFiling

  2. 2 Form 4 sale ARVNPlan not stated
    Aug 16, 2021 +133 days

    Sold 20,000 shares at $87.30 ($1.7M)

    Taylor Ian, Chief Scientific Officer

    Sold 20.3% of holdings ($8.6M position)78,645 shares left2x usual sizeFiling

  3. 3 Form 4 sale ARVNPlan not stated
    Nov 15, 2021 +91 days

    Sold 20,000 shares at $84.04 ($1.7M)

    Taylor Ian, Chief Scientific Officer

    Sold 20.3% of holdings ($8.3M position)78,645 shares left1.9x usual sizeFiling

  4. 4 Form 4 sale ARVNPlan not stated
    Feb 15, 2022 +92 days

    Sold 20,000 shares at $73.02 ($1.5M)

    Taylor Ian, Chief Scientific Officer

    Sold 20.3% of holdings ($7.2M position)78,645 shares left1x usual sizeFiling

  5. 5 Form 4 sale ARVNPlan not stated
    Mar 4, 2022 +17 days

    Sold 869 shares at $63.94 ($56k)

    Taylor Ian, Chief Scientific Officer

    Sold 1% of holdings ($5.4M position)83,962 shares left0x usual sizeFiling

  6. 6 Form 4 sale ARVNPlan not stated
    Mar 1, 2023 +362 days

    Sold 1,051 shares at $29.53 ($31k)

    Taylor Ian, Chief Scientific Officer

    Sold 1% of holdings ($3M position)101,721 shares left0.1x usual sizeFiling

  7. 7 Form 4 sale ARVNNo plan
    Feb 23, 2024 +359 days

    Sold 1,701 shares at $47.05 ($80k)

    Taylor Ian, Chief Scientific Officer

    No 10b5-1 planSold 1.1% of holdings ($7M position)147,522 shares leftFiling

  8. 8 Form 4 sale ARVNNo plan
    Feb 24, 2025 +367 days

    Sold 9,020 shares at $16.71 ($151k)

    Taylor Ian, President, R&D

    No 10b5-1 planSold 5.4% of holdings ($2.8M position)159,121 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (13)

Form 144 notices and Form 4 sales by Taylor Ian
Source
Feb 24, 2025Feb 25, 2025ARVNPresident, R&DForm 4 sale9,020$151k5.4%No planSEC
Feb 23, 2024Feb 27, 2024ARVNChief Scientific OfficerForm 4 sale1,701$80k1.1%No planSEC
Mar 1, 2023Mar 3, 2023ARVNChief Scientific OfficerForm 4 sale1,051$31k1.0%Plan not statedSEC
Mar 4, 2022Mar 4, 2022ARVNChief Scientific OfficerForm 4 sale869$56k1.0%Plan not statedSEC
Feb 15, 2022Feb 17, 2022ARVNChief Scientific OfficerForm 4 sale20,000$1.5M20.3%Plan not statedSEC
Nov 15, 2021Nov 17, 2021ARVNChief Scientific OfficerForm 4 sale20,000$1.7M20.3%Plan not statedSEC
Aug 16, 2021Aug 18, 2021ARVNChief Scientific OfficerForm 4 sale20,000$1.7M20.3%Plan not statedSEC
Apr 5, 2021Apr 7, 2021ARVNChief Scientific OfficerForm 4 sale25,000$1.7M24.1%Plan not statedSEC
Mar 2, 2021Mar 2, 2021ARVNChief Scientific OfficerForm 4 sale894$69k1.1%Plan not statedSEC
Mar 19, 2020Mar 23, 2020ARVNChief Scientific OfficerForm 4 sale826$31k1.2%Plan not statedSEC
Nov 13, 2019Nov 15, 2019ARVNChief Scientific OfficerForm 4 sale10,000$280k15.3%Plan not statedSEC
Nov 5, 2019Nov 7, 2019ARVNChief Scientific OfficerForm 4 sale10,000$236k13.2%Plan not statedSEC
Sep 30, 2019Oct 2, 2019ARVNChief Scientific OfficerForm 4 sale10,000$219k11.7%Plan not statedSEC